APA (7th ed.) Citation

Xu, X. (2018). Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression [Neuropharmacology]. The American Society for Pharmacology and Experimental Therapeutics.

Chicago Style (17th ed.) Citation

Xu, X. Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression [Neuropharmacology]. The American Society for Pharmacology and Experimental Therapeutics, 2018.

MLA (9th ed.) Citation

Xu, X. Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression [Neuropharmacology]. The American Society for Pharmacology and Experimental Therapeutics, 2018.